Artificial intelligence (AI) - based analyses is particularly well suited to analyze high-resolution three-dimensional retinal images in an automated accurate and real-time manner.
Our group has developed AI-based tools able to perform screening, monitoring of disease activity and therapeutic response and risk/outcome prediction for the leading retinal diseases in the clinical practice.
Friday, 18 November 2022 @ 12:00 CET
On-site:
University of Vienna
Seminarraum 8
Kolingasse 14-16
1090 Vienna
Online:
https://us06web.zoom.us/j/83157161932?pwd=S1dCMytibUY1cldqR1p3akZBYWlKUT09
Meeting-ID: 831 5716 1932
Passcode: 175842
